Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00460187 · ClinicalTrials.gov registry record · NA
EPIC US Pivotal Study
A NA study of Percutaneous Intervention of the Carotid Arteries., sponsored by Lumen Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 237
- Enrollment target
- 2
- Study locations
NCT00460187 is a NA study of Percutaneous Intervention of the Carotid Arteries. that has completed, run by Lumen Biomedical. The registered enrollment target is 237 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT00460187, a NA study of Percutaneous Intervention of the Carotid Arteries., has completed, sponsored by Lumen Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multicenter, prospective, pivotal study designed to demonstrate the safety and efficacy of the Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention in high surgical risk patients.
Conditions Studied
Interventions
- DEVICE Percutaneous intervention of the carotid artery
Study Locations (2)
California
- Hoag Hospital - Newport Beach
South Dakota
- Heart Hospital of South Dakota - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00460187
The ClinicalTrials.gov registry entry for NCT00460187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumen Biomedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Percutaneous Intervention of the Carotid Arteries. appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous intervention of the carotid artery is the first listed.
NCT00460187 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, South Dakota.
Frequently Asked Questions
What is clinical trial NCT00460187 about?
NCT00460187 is a clinical study titled "EPIC US Pivotal Study". Multicenter, prospective, pivotal study designed to demonstrate the safety and efficacy of the Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention in high surgical risk patients.
What is the current status of trial NCT00460187?
This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2007-03. Estimated completion is 2008-06.
What conditions does trial NCT00460187 study?
This clinical trial studies the following conditions: Percutaneous Intervention of the Carotid Arteries..
What interventions are being tested in trial NCT00460187?
The interventions under investigation include: Percutaneous intervention of the carotid artery (DEVICE).
Who is sponsoring clinical trial NCT00460187?
This trial is sponsored by Lumen Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00460187 being conducted?
This trial has 2 study locations across California, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.